Sign in

JAMA Health Forum

@jamahealthforum.com
618 followers 143 following 428 posts

JAMA Health Forum is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. 🌐 JAMAHealthForum.com

PostsRepliesMedia
JAMA Health Forum @jamahealthforum.com · 25/09/2026
In Pennsylvania, nonprofit #AmbulatorySurgeryCenters had higher profit margins than for-profit centers and accounted for a larger share of total net income relative to their share of facilities. ja.ma/4cYTqW2
033
JAMA Health Forum @jamahealthforum.com · 25/09/2026
In Medicaid, covering obesity-labeled #GLP1 receptor agonists was associated with higher obesity-labeled use, while total glucagon-like peptide-1 receptor agonist use increased less, suggesting possible substitution across label indications. ja.ma/4xPkKxn
021
Reposted by JAMA Health Forum
Solomon Center @ YLS @solomonctryls.bsky.social · 10/09/2026
In @jamahealthforum.com, Solomon Center affiliated faculty @zackcooperyale.bsky.social finds that health spending growth explained 91% of the 2011–2024 rise in private insurance premiums, suggesting efforts to slow premium growth should focus on spending. jamanetwork.com/journals/jam...
jamanetwork.com
Health Care Spending and Insurance Premiums Among the Privately Insured
This cohort study analyzes the extent to which rising health insurance premiums reflect growth in health spending vs growth in markups in the large-group market, small-group market, and in the health ...
021
Reposted by JAMA Health Forum
Joshua Sharfstein @drjoshs.bsky.social · 25/09/2026
This week, in @jamahealthforum.com, I tackle the question of regulating AI agents in medicine ... Spoiler alert: I am not calling for treating them like human clinicians. jamanetwork.com/journals/jam...
jamanetwork.com
Overseeing Agentic AI in Medicine From First Principles
This JAMA Forum discusses the use of artificial intelligence (AI) agents in health care, the need for regulation based on risk, and ways to share responsibility and adapt quickly.
112
JAMA Health Forum @jamahealthforum.com · 19/09/2026
📊 Among Medicare beneficiaries who reached the Inflation Reduction Act Part D cap in 2025, most without a low-income subsidy paid less than the full $2000 out of pocket, with lower payments in Medicare Advantage plans vs stand-alone Part D plans ja.ma/4jby4s5
Bar graphs show mean beneficiary-paid amount towards a $2000 cap by quarter & Part D enrollment in 2025. PDP (non-LIS) (pink) is highest (~$1200-1500), MAPD (non-LIS) (green) lower (~$800-1200), LIS (blue) is minimal. Data for Overall & Quarters 1-4. Y-axis: payment ($).
000
JAMA Health Forum @jamahealthforum.com · 19/09/2026
📝 Viewpoint: #SchoolBasedHealthServices support student health and educational achievement, but projected federal Medicaid reductions under the One Big Beautiful Bill Act may disrupt access to these services, particularly in low-income and rural districts ja.ma/4yPdN0h
Document titled 'Viewpoint: Federal Funding Cuts and the Future of Health Care in Schools' by Angélica Meinhofer, Caroline H. Kelly, Sasha Pudelski, and Jessie Mandle. It discusses school-based health services funding & the impact of a new bill on Medicaid.
000
JAMA Health Forum @jamahealthforum.com · 18/09/2026
Across 41 states, millions of people lived in #Broadband deserts, most of them in rural areas, with many also facing limited access to ambulance and health care services. ja.ma/4gWPzLs
000
JAMA Health Forum @jamahealthforum.com · 18/09/2026
For adults with #schizophrenia, #CommunityBasedRehabilitation was associated with improved outcomes and cost savings across health system, multipayer, and societal perspectives in a resource-constrained setting. ja.ma/4ivP38k
Table 3, titled 'Cost-Effectiveness Results of Community-Based Rehabilitation Among People With Schizophrenia in China', presents financial and effectiveness data for QALYs, PANSS, PSP, and BAS scores from health system, multipayer, and societal perspectives.
010
JAMA Health Forum @jamahealthforum.com · 14/09/2026
Katy Backes Kozhimannil, PhD, MPA, of the University of Minnesota joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, to discuss health policy and improving health for rural populations. ja.ma/4gQ9aeL
010
JAMA Health Forum @jamahealthforum.com · 13/09/2026
Consolidation of #GroupPurchasingOrganizations may have policy implications for competition, contracting practices, drug shortages, and hospital purchasing power in the US supply chain. ja.ma/46Kl4SQ
001
JAMA Health Forum @jamahealthforum.com · 12/09/2026
Explicit policies on #CognitiveDecline in aging physicians are uncommon across G7 countries, and age-based assessments in medicine raise ethical, legal, and practical tensions not seen to the same degree in other safety-critical professions. ja.ma/3TbsAmG
000
JAMA Health Forum @jamahealthforum.com · 11/09/2026
Among rural and urban hospitals that provided obstetric services, lower birth volume, unprofitability, proximity to another obstetric hospital, and for-profit status were associated with loss of hospital-based #ObstetricCare ja.ma/4hghFAn
012
JAMA Health Forum @jamahealthforum.com · 11/09/2026
Among patients with #EndStageRenalDisease receiving dialysis, nephrologist participation in the voluntary Kidney Care Choices model was associated with higher home dialysis use vs participation in neither model. ja.ma/4yksRTb
000
JAMA Health Forum @jamahealthforum.com · 11/09/2026
📝 Editorial: The Rural Health Transformation Program creates an opportunity to study which policies, payment models, and workforce strategies improve #RuralHealth and population health. ja.ma/4xc9Bq3
000
JAMA Health Forum @jamahealthforum.com · 11/09/2026
📝 Viewpoint: The article indicates that legal and contractual barriers to cash pricing may limit transparent, consumer-facing options and keep #HealthCare prices higher for patients. ja.ma/4iOJ1zI
001
JAMA Health Forum @jamahealthforum.com · 07/09/2026
In Virginia, preventive care reimbursement in #Medicaid managed care exceeded Medicaid fee-for-service, but remained below rates paid by employer-sponsored insurance, Marketplace plans, and #MedicareAdvantage. ja.ma/4rhwU0x
Figure 1. Four box plots show 2023 physician preventive care rates in Virginia. Rates vary by CPT code (99385, 99386, 99395, 99396) and insurance plan (ESI, Marketplace, MA, Medicaid MCO). A dashed line indicates $100.
000
JAMA Health Forum @jamahealthforum.com · 07/09/2026
In privately insured patients, rising #HealthInsurance premiums were largely associated with growth in health spending rather than growth in insurer markups. Efforts to slow premium growth may need to focus on reducing underlying health care spending. ja.ma/4yJiskr
Two graphs, 2011-2024. Left: Line graph shows mean insurance premiums ($) (orange) consistently higher & increasing faster than mean health spending ($) (blue). Right: Bar graph shows insurer markup (%) fluctuating, with highs around 2018-2020.
000
JAMA Health Forum @jamahealthforum.com · 07/09/2026
In teenagers and young adults, #SocialMedia warnings about health harms were perceived as more effective than a screen time break warning for discouraging use and increasing awareness of harm. ja.ma/46HHjZA
ja.ma
Designing Social Media Health Warnings for Teenagers and Young Adults
This randomized clinical trial examines whether teenagers and young adults perceive that social media warnings discourage them from wanting to use social media and increase their awareness of the harms of social media.
000
JAMA Health Forum @jamahealthforum.com · 07/09/2026
In adults with #ChronicPain and mental health need, private insurance was associated with larger #MentalHealth utilization gaps and more cost-related barriers than military or #VeteransAffairs coverage. ja.ma/3UZ6p3z
ja.ma
Mental Health Utilization Gap by Insurance Type Among US Adults With Chronic Pain
This cross-sectional study examines the association between insurance type and mental health service utilization among US adults with chronic pain.
021
JAMA Health Forum @jamahealthforum.com · 07/09/2026
📝 Viewpoint: A single-trial default for #FDA drug approval may speed access, but it could also reduce evidentiary certainty and increase the risk of nonreplicable or ambiguous findings. ja.ma/46bcY5D
ja.ma
Opportunities and Risks of a Single-Trial Default for FDA Drug Approval
This Viewpoint describes potential concerns and opportunities with a single-trial default for US Food and Drug Administration (FDA) drug approval.
010
JAMA Health Forum @jamahealthforum.com · 06/09/2026
Among commercially insured adults with #Obesity initiating semaglutide, higher out-of-pocket costs were associated with lower adherence, indicating that financial barriers may limit sustained use and reduce access to the benefits of treatment. ja.ma/4yis8Sw
Two line graphs showing adjusted differences in (A) predicted nonadherence and (B) proportion of days covered for Semaglutide by out-of-pocket cost quintile (Q1-Q5). Nonadherence probability (vs Q1) rises to ~0.09 by Q5. Days covered probability drops to ~-0.08 by Q5.
033
JAMA Health Forum @jamahealthforum.com · 06/09/2026
#Medicaid work-reporting requirements may place working adults at risk of coverage loss even when they are employed, because near-threshold or inconsistent work hours can lead to noncompliance. ja.ma/4cwp3G8
US map showing states categorized by the proportion of adults (18-64) at risk of Medicaid noncompliance subject to work requirements. Legend: >20% (darkest), 15-20%, <15% (lightest), and Excluded (gray). Many southern/midwestern states are excluded.
000
JAMA Health Forum @jamahealthforum.com · 06/09/2026
Natural language processing of #Medicaid care coordination notes identified paperwork, scheduling, transportation, and #PriorAuthorization delays as major administrative burdens and offers a scalable way to monitor burden by type. ja.ma/4gPBA8P
Circle plot: Administrative burden prevalence (%) vs. time cost per patient ($). Circle size = affected patients. Transportation (12k patients) highest cost ~$47, low prevalence (~7%). Paperwork (6k patients) highest prevalence (~25%), moderate cost (~$23). Scheduling (6k patients) lowest cost ~$11. Prior auth (2k patients) moderate cost ~$18, low prevalence.
020
JAMA Health Forum @jamahealthforum.com · 06/09/2026
📝 Viewpoint: Prescription-to-#OverTheCounter switching may improve convenience and some forms of access, but without reimbursement for pharmacist-led care and patient education, it may shift cost and risk to patients. ja.ma/4xbh20C
Webpage showing a JAMA Health Forum article titled "Prescription to Over-the-Counter Switching as a Policy Tool." Authors are T. Joseph Mattingly II and Rena M. Conti. Published online August 28, 2026.
000
JAMA Health Forum @jamahealthforum.com · 06/09/2026
The 2016 Brexit referendum was associated with increased #NHS physician vacancies, indicating that higher non-EU recruitment did not fully offset workforce shortages. ja.ma/4qZyrb9
Three line graphs chart nurse inflow to the UK (EU, Non-EU, Total), showing 'nurses who emigrated' 2008-2019. Post-2016 Brexit referendum, observed EU inflow sharply dropped. Non-EU inflow dipped then rose sharply. Total inflow fell, partially recovering below predicted trends.
031
JAMA Health Forum @jamahealthforum.com · 06/09/2026
Among #MedicareAdvantage beneficiaries, new complex medical conditions were associated with higher disenrollment, especially to #TraditionalMedicare, and the increase grew with the number of conditions. ja.ma/4r5KwvG
Three line graphs show enrollment (2017-2021) for TM/MA plans by number of new conditions. Post-2019, Enrollment in TM (B) rises sharply for patients with new conditions, especially ≥4 (reaching >25%). Enrollment in different MA plans (C) slightly decreases for all categories.
020
JAMA Health Forum @jamahealthforum.com · 06/09/2026
Among #MedicareAdvantage beneficiaries, new complex medical conditions were associated with higher disenrollment, especially to #TraditionalMedicare, and the increase grew with the number of conditions. ja.ma/4igpOqr
ja.ma
Medicare Advantage Beneficiary Enrollment Decisions Following New Complex Conditions
This cohort study examines changes in Medicare Advantage plan disenrollment following the development of new complex medical conditions and assesses heterogeneity by number of conditions, state Medigap policy, and plan characteristics.
010
JAMA Health Forum @jamahealthforum.com · 28/08/2026
⏰ Last call! Applications for the JAMA Health Forum Editorial Fellowship program are due Tuesday, September 1. 🔗 Find the requirements and application details here: ja.ma/4fR5jh8
JAMA Health Forum and JN logo. Text: Call for Applications: Editorial Fellowship, Due September 1, 2026. The background shows hands typing on a laptop keyboard with a blue overlay.
011
JAMA Health Forum @jamahealthforum.com · 24/08/2026
JAMA Health Forum is offering three editorial fellowship positions in different areas of focus for doctoral scholars interested in working with a health policy and health services journal. 📅 Deadline: Sept 1, 2026 🔗 ja.ma/45B8k0m
JAMA Health Forum™ logo above a blue-tinted image of hands typing on a laptop. Overlay text: "Call for Applications: Editorial Fellowship. Due September 1, 2026." A "JN®" logo is in the bottom left.
001
JAMA Health Forum @jamahealthforum.com · 22/08/2026
JAMA Health Forum is offering three editorial fellowship positions in different areas of focus for doctoral scholars interested in working with a health policy and health services journal. 📅 Deadline: Sept 1, 2026 🔗 ja.ma/4fQamyD
JAMA Health Forum™ and JN logos. Text: "Call for Applications: Editorial Fellowship Due September 1, 2026." A person's hands type on a laptop keyboard, shown with a blue overlay.
001
JAMA Health Forum @jamahealthforum.com · 21/08/2026
💬 Viewpoint by Dhruv Khullar, MD, MPP, Sachin Jain, MD, MBA, and Amelia Bond, PhD: Voluntary multiyear enrollment in #MedicareAdvantage could reduce annual churn and better support preventive care, chronic disease management, and care continuity. ja.ma/4c449Oj
Webpage displaying a JAMA Health Forum 'Viewpoint' article: 'Toward Multiyear Enrollment in Medicare Advantage.' Authored by Dhruv Khullar, Sachin H. Jain, and Amelia M. Bond. Published Online: August 21, 2026. The page includes navigation and interaction icons.
000
JAMA Health Forum @jamahealthforum.com · 21/08/2026
New complex medical conditions were associated with higher #MedicareAdvantage disenrollment, especially to traditional Medicare, and disenrollment increased with the number of new conditions. ja.ma/4gL5s7u
Three line graphs show enrollment percentages (2017-2021). A vertical line marks 2019. Legend: No to ≥4 new complex conditions. Graph A: Enrollment in TM or different MA plan. Graph B: Enrollment in TM. Graph C: Enrollment in different MA plan. Post-2019, TM enrollment (B) rises sharply for those with more new conditions, while other MA plan enrollment (C) declines for all conditions.
000
JAMA Health Forum @jamahealthforum.com · 21/08/2026
After the Brexit referendum, European Union #Physicians and #Nurses immigrating to the UK declined, while non–European Union recruitment increased and National Health Service physician vacancies rose. ja.ma/45GQd9n
Three graphs display UK nurse inflow 2008-2019. After the 2016 Brexit referendum: EU nurse inflow sharply dropped from predicted levels. Non-EU inflow dipped then increased. Total nurse inflow dipped then recovered. Control countries' inflow remained low.
021
JAMA Health Forum @jamahealthforum.com · 18/08/2026
JAMA Health Forum is seeking editorial fellows for a 1-year, hands-on fellowship program beginning January 1, 2027. Fellows will receive training in the editorial processes and policies of a major health policy and health services journal. 📅 Apply by Sept 1: ja.ma/4fina04
JAMA Health Forum logo above text: “Call for Applications: Editorial Fellowship. Due September 1, 2026.” A circular JN logo is also present. The background shows hands typing on a laptop keyboard, overlaid with a translucent blue filter.
010
JAMA Health Forum @jamahealthforum.com · 15/08/2026
💬 Editorial by JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, and Nason Maani, PhD: Research on commercial determinants of health can help clarify how corporate practices and policy environments shape #HealthEquity and population health. ja.ma/4hwkMG1
JAMA Health Forum article page displaying an Editorial titled 'Centering Corporate Activity in the Population Health Research Agenda' by Sandro Galea and Nason Maani. Published Online: August 14, 2026, with publication details and DOI.
000
JAMA Health Forum @jamahealthforum.com · 15/08/2026
Patients classified as likely undocumented had higher in-person outpatient visit completion overall, but month-specific declines in 2025 and increased #Telehealth use indicate shifts in access during intensified federal immigration enforcement. ja.ma/4zksxFo
Line graph: Change in outpatient visit completion rate (%), 2024-2025, over 6 months. 'NEPL without SSN' (orange) starts high at 4.3%, drops to -3% (month 3), then rises and falls. 'EPL with SSN' (teal) starts at 1.5%, drops to -1.8% (month 2), then steadily rises.
001
JAMA Health Forum @jamahealthforum.com · 15/08/2026
As #DualEligibleSpecialNeedsPlans expanded, higher maximum out-of-pocket limits after the 2023 policy change may shift payment responsibility from state #Medicaid programs to #MedicareAdvantage organizations earlier in the spending trajectory. ja.ma/4bSxPxT
Line graph showing Mean MOOP limit ($) from 2017-2026. A "MOOP recalculation" in 2023 causes all lines to increase sharply. Combined (D-SNPs) and Combined (non-SNPs) lines are highest. In network (D-SNPs) and In network (non-SNPs) lines are lower.
000
JAMA Health Forum @jamahealthforum.com · 15/08/2026
State #EvictionMoratoria were associated with fewer foster care entries related to inadequate housing, caregiver inability to cope, and physical abuse, but not with a significant difference in total foster care entries. ja.ma/4x0nZ5r
Four line graphs display adjusted foster care entry rate indices for 'Always treated' (dark grey) and 'Never treated' (orange) groups, from Jan 2019 to Aug 2021. A vertical line marks 'EM implementation' in Mar 2020. All graphs show rates declining for total, physical abuse, caregiver inability, and inadequate housing after EM implementation.
000
JAMA Health Forum @jamahealthforum.com · 15/08/2026
For high-cost #PrescriptionDrugs, a #RealTimePrescriptionBenefit tool was associated with higher fill rates, suggesting a targeted approach may better reduce cost-related nonadherence than universal deployment. ja.ma/3SdUzl7
JAMA Health Forum study: RCT on Real-Time Prescription Benefit Tool (RTPB) & Prescription Fill Rates. Of 38,289 orders, RTPB (23,226 orders) offered lower-cost alternatives vs. control (15,063 orders). Bar chart shows RTPB increased high-cost drug fill rates from 33% to 49%, and overall from 54% to 55%. Study in 1 US ambulatory network.
010
JAMA Health Forum @jamahealthforum.com · 13/08/2026
📢 Now accepting applications: 2027 JAMA Health Forum editorial Fellowship. Scholars with a doctoral degree interested in the policies that shape health are encouraged to apply for this fellowship to receive hands on training. Applications due September 1, 2026. 🔗 ja.ma/4fina04
JAMA Health Forum™ logo above text: "Call for Applications: Editorial Fellowship. Due September 1, 2026." The background shows hands typing on a laptop keyboard with a blue filter. A "JN" logo is in the lower left corner.
000
JAMA Health Forum @jamahealthforum.com · 10/08/2026
Biologics and therapeutics from larger companies reached #MostFavoredNation markets sooner than small-molecule drugs and products from smaller companies, which may affect Medicare pricing benchmarks under GLOBE and GUARD. ja.ma/4fIIVrA
Table 1: Characteristics & MFN Market Launches of FDA-Approved Therapeutics for GLOBE/GUARD Models. Summarizes 79 drugs by type, area, origin, & approval status. Shows median months to 1st MFN launch (6.3) & % launched in ≥1 MFN country by 5 years (91.1%).
000
JAMA Health Forum @jamahealthforum.com · 09/08/2026
📣 Special Communication: For #Medicaid work requirements under the Budget Reconciliation Act of 2025, #ArtificialIntelligence could help states screen eligibility, review documentation, and identify people at risk of procedural disenrollment. ja.ma/45eyS7C
Table: AI Augmentation of Health Care Policy Implementation. It details five domains: Process execution, Targeting, Communication, Monitoring, and Adaptation. For each domain, it lists Medicaid work requirement implementation needs and provides AI-augmented policy examples. Abbreviations: AI, LLM.
000
JAMA Health Forum @jamahealthforum.com · 09/08/2026
After New York State expanded #Medicaid and #MedicareSavingsProgram eligibility in 2023, dual enrollment among Medicare beneficiaries rose above projected levels, indicating broader access to financial assistance. ja.ma/4q4OdkI
Two graphs show enrollment trends (Jan 2021-Nov 2023). Graph A: Enrollment percentage for Medicaid (without MSP) sharply drops in early 2023, while Medicaid and MSP percentage rises. Graph B: Number of enrollees for Medicaid (without MSP) decreases significantly as Medicaid and MSP increases, while MSP (without Medicaid) remains stable in both.
010
JAMA Health Forum @jamahealthforum.com · 09/08/2026
In US #NursingHome markets, ownership transitions and bed-capacity changes became more common over time than permanent closure, indicating that organizational restructuring is a central market dynamic. ja.ma/4xtqnBz
Stacked bar chart showing the number of events by type from 1985 to 2025. Total events (Termination, Entry, Capacity change, CHOW) decrease sharply from ~7500 in 1985 (mainly Termination) to under 1000 by 2025, where Capacity change is highest.
010
JAMA Health Forum @jamahealthforum.com · 09/08/2026
JAMA Health Forum is offering three editorial fellowship positions in different areas of focus for doctoral scholars interested in working with a health policy and health services journal. 📅 Deadline: Sept 1, 2026 🔗 ja.ma/3RMEkva
JAMA Health Forum logo & JN icon. Call for Applications: Editorial Fellowship, due September 1, 2026. Hands are typing on a laptop keyboard, with a blue translucent overlay.
000
JAMA Health Forum @jamahealthforum.com · 08/08/2026
Among high-risk therapeutic #MedicalDevices approved through the US Food and Drug Administration premarket approval pathway, more than 1-third were later subject to serious recalls, supporting stronger postmarket surveillance. ja.ma/4z5Nh3u
Two graphs. A) Serious (Class I or II) recalls: Percentage of devices with recalls rises from 0% to ~45% over 11 years. No. at risk starts at 193. B) Class I recalls: Percentage of devices with Class I recalls rises from 0% to ~15% over 11 years. Both have shaded confidence intervals.
002
JAMA Health Forum @jamahealthforum.com · 08/08/2026
Mandatory #ValueBasedCare programs by the Centers for Medicare & Medicaid Services were associated with higher hospital administrative costs, adding more than $3 billion in annual costs nationally. ja.ma/4z1C1oZ
Three line graphs show annual administrative costs per hospital (Maryland acute, critical access, long-term acute) from 2008-2017. All show costs near zero until 2012, then rising significantly over time, with increasing confidence intervals. Cost estimate and 95% CI are indicated.
000
JAMA Health Forum @jamahealthforum.com · 08/08/2026
Expanding #Alcohol screening and brief intervention in primary care was projected to reduce premature mortality by 2030, especially when brief intervention delivery increased substantially. ja.ma/4fXJoFg
Two bar charts show reduction in education gaps. Chart A: YLL per 100,000 for 4 scenarios: Screening expansion (+20M), +4M interventions, +8M interventions, and Universal ASBI. Universal ASBI has the largest YLL reduction. Chart B: Percentage reduction for same scenarios, for Women and Men. Universal ASBI shows largest % reduction for both. All include error bars.
000
JAMA Health Forum @jamahealthforum.com · 05/08/2026
JAMA Health Forum is seeking editorial fellows for a 1-year, hands-on fellowship program beginning January 1, 2027. Fellows will receive training in the editorial processes and policies of a major health policy and health services journal. 📅 Apply by Sept 1: ja.ma/4fina04
JAMA Health Forum announces a 'Call for Applications: Editorial Fellowship.' Deadline: 'Due September 1, 2026.' Background shows hands typing on a laptop keyboard.
020
JAMA Health Forum @jamahealthforum.com · 04/08/2026
Across the US, France, Germany, and Switzerland, median total time from clinical trial initiation to reimbursement for new #Drugs changed little from 2014 to 2024. ja.ma/4bLjFP9
Stacked bar chart of drug approval timelines across US, France, Germany, Switzerland. It shows years for Clinical Development, Regulatory Review, & Reimbursement Review for All, Standard, & Expedited processes, highlighting varying durations per stage & process type.
000